📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Complement downregulation promotes an inflammatory signature that renders colorectal cancer susceptible to immunotherapy. (2022)

First Author: Krieg C

Attributed to: MICA: Stratification in COloRectal cancer: from biology to Treatment prediction: S-CORT funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jitc-2022-004717

PubMed Identifier: 36137652

Publication URI: http://europepmc.org/abstract/MED/36137652

Type: Journal Article/Review

Volume: 10

Parent Publication: Journal for immunotherapy of cancer

Issue: 9

ISSN: 2051-1426